Zai Lab Ltd (NAS:ZLAB)
$ 17.92 -1.14 (-5.98%) Market Cap: 1.79 Bil Enterprise Value: 1.34 Bil PE Ratio: 0 PB Ratio: 2.43 GF Score: 67/100

Zai Lab Ltd Topline POC Data Readout of ZL-1102 Corporate Call Transcript

Oct 21, 2021 / 12:00PM GMT
Release Date Price: $99.72 (-0.01%)
Operator

Good day, and thank you for standing by. Welcome to the top line POC data readout of ZL-1102. (Operator Instructions) For participants who dialed into the teleconference, you can access the slides via webcast link posted on the company IR's site. (Operator Instructions) And please be advised that today's conference is being recorded. (Operator Instructions)

Now I'd like to hand the conference over to your first speaker for today, Mr. Billy Cho. Please go ahead.

Ki Chul Cho
Zai Lab Limited - CFO

Good morning, ladies and gentlemen. I'm Billy Cho, Chief Financial Officer of Zai Lab. We are holding this conference call to share exciting news about our early development candidate, ZL-1102. And Dr. Reinhart, Chief Medical Officer at Zai Lab for the Autoimmune and Infectious Diseases Therapeutic Areas, will make a brief presentation and then take your questions.

Turn to Slide 2, please. As a reminder, during today's call, Zai Lab will be making certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot